Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi

Detalhes bibliográficos
Autor(a) principal: BARROS, Eduarda Pereira de
Data de Publicação: 2021
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Digital Unicesumar
Texto Completo: http://rdu.unicesumar.edu.br/handle/123456789/7576
Resumo: The trypanosoma cruzi is a protozoan that causes a serious infeccion in the vertebrate host, being capable of causing irreversible damages, mainly in the muscle cells, also known as trypanosomiasis disease or Chagas Disease. The commercially avaible drug medication wich fights this parasite is not completly eficiente and causes undesireble and irreversible damages, making it necessary to search for other fields of medicine, in terms of medication, to combat this disease. Therefore, research with homeopathic medicines has being promising in the fight against the parasite, especially the amastigote forms, which are more difficult to be exterminated. Biotherapics are the homeopathic ones that have been more successful in relation to T. cruzi infection, since these drugs have their active principle removed from the parasite itself, its toxins, part of its members, performing a therapy known as isotherapy - cure by the same. The work was carried out with analysis of 100 histological slides, in 'zigzag', 'listing cells, infected or not by amastigotes, as well as cells of innate or acquired immunity. The work had the existence of three groups: control, treated continuously and treated only at the beginning of the infection. The results indicates that the 200dH biotherapic acts by coercing the immune system to fight T. cruzi in contaminated guinea pigs, promoting a cellular and humoral imune response more efficient than the physiological one. It is believed that this medicine works by stimulating the defense cells, which will respond in an antigenspecific manner, favoring the fight against amastigotes. This process is probably initiated by the stimulation of the macrophage, which in turn, according to the remains found, initiates an inflammatory cascade, with predominance of the Th1 pathway, promoting the production of IL-4e IL-5 and γ interferon, helping to combat amastigotes. With this result, the cure for homeopathy, of an infectious disease, shows promise, being an innovative and important field of medicine, requiring further investigation.
id UNICESU -1_1f4d5b03297c7a86deff5c28ef10446a
oai_identifier_str oai:rdu.unicesumar.edu.br:123456789/7576
network_acronym_str UNICESU -1
network_name_str Repositório Digital Unicesumar
repository_id_str
spelling Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruziBioterápicosDoença de ChagasHomeopatiaT. cruziCNPQ::CIENCIAS DA SAUDE::MEDICINAThe trypanosoma cruzi is a protozoan that causes a serious infeccion in the vertebrate host, being capable of causing irreversible damages, mainly in the muscle cells, also known as trypanosomiasis disease or Chagas Disease. The commercially avaible drug medication wich fights this parasite is not completly eficiente and causes undesireble and irreversible damages, making it necessary to search for other fields of medicine, in terms of medication, to combat this disease. Therefore, research with homeopathic medicines has being promising in the fight against the parasite, especially the amastigote forms, which are more difficult to be exterminated. Biotherapics are the homeopathic ones that have been more successful in relation to T. cruzi infection, since these drugs have their active principle removed from the parasite itself, its toxins, part of its members, performing a therapy known as isotherapy - cure by the same. The work was carried out with analysis of 100 histological slides, in 'zigzag', 'listing cells, infected or not by amastigotes, as well as cells of innate or acquired immunity. The work had the existence of three groups: control, treated continuously and treated only at the beginning of the infection. The results indicates that the 200dH biotherapic acts by coercing the immune system to fight T. cruzi in contaminated guinea pigs, promoting a cellular and humoral imune response more efficient than the physiological one. It is believed that this medicine works by stimulating the defense cells, which will respond in an antigenspecific manner, favoring the fight against amastigotes. This process is probably initiated by the stimulation of the macrophage, which in turn, according to the remains found, initiates an inflammatory cascade, with predominance of the Th1 pathway, promoting the production of IL-4e IL-5 and γ interferon, helping to combat amastigotes. With this result, the cure for homeopathy, of an infectious disease, shows promise, being an innovative and important field of medicine, requiring further investigation.O Tripanosoma cruzi é um protozoário que instaura uma infecção grave em seu hospedeiro vertebrado, podendo causar danos irreversíveis, principalmente em suas células musculares, conhecida como a doença tripanossomíase ou Doença de Chagas. A medicação disponível no mercado, que combate esse parasito, não é completamente eficiente e produz danos indesejáveis e irreversíveis, fazendo-se necessário a busca por outros campos da medicina, em termos de medicação, para combater essa doença. Nesse sentido, pesquisas com medicamentos homeopáticos têm se revelado promissoras no combate ao parasito, sobretudo as formas amastigotas, que são mais difíceis de serem exterminadas. Os bioterápicos são os homeopáticos que obtiveram maior sucesso em relação à infecção por T. cruzi, uma vez que esses medicamentos possuem seu princípio ativo retirado do próprio parasito, suas toxinas, parte de membras, realizando uma terapia conhecida como isoterapia – cura pelo igual. O trabalho foi realizado com analise de 100 lâminas histológicas, em ‘ziguezague’’, cotando células, infectadas ou não pelas amastigotas, bem como células da imunidade inata ou adquirida. O trabalho contou com a existência de três grupos: controle, tratado continuamente e tratado apenas no início da infecção. Resultados encontrados indicam que o bioterápico 200dH atua coagindo o sistema imune a combater o T. cruzi em cobaias contaminadas, fomentando uma resposta imune celular e humoral mais eficiente do que a fisiológica. Acredita-se que esse medicamento atue estimulando as células de defesa, que passarão a responder de forma antígeno-específico, favorecendo o combate de amastigotas. Esse processo, provavelmente, é iniciado pela estimulação do macrófago, que por sua vez, de acordo com os resultados encontrados, inicia uma cascata inflamatória, com predominância da via Th1, fomentando a produção de IL4, IL-10 e interferon γ, auxiliando no combate as amastigotas. Com esse resultado, a cura pela homeopatia, de uma doença infecciosa, se demonstra promissora, sendo um campo inovador e importante da medicina, necessitando de mais investigação.UNIVERSIDADE CESUMARBrasilUNICESUMAROLIVEIRA, Simone Martins deOLIVEIRA, Simone Martins deSILVA, Maria Fernanda Piffer Tomasi Baldez daBARROS, Eduarda Pereira de2021-02-16T14:46:46Z2021-02-162021-02-16T14:46:46Z2021-02-16info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfBARROS, Eduarda Pereira de. Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi. 16f. 2020. Unicesumar - Universidade Cesumar: Maringá 2020.Presencialhttp://rdu.unicesumar.edu.br/handle/123456789/7576porinfo:eu-repo/semantics/openAccessreponame:Repositório Digital Unicesumarinstname:Centro Universitário de Maringá (UNICESUMAR)instacron:UniCesumar2021-02-17T06:02:10ZRepositório InstitucionalPRI
dc.title.none.fl_str_mv Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi
title Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi
spellingShingle Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi
BARROS, Eduarda Pereira de
Bioterápicos
Doença de Chagas
Homeopatia
T. cruzi
CNPQ::CIENCIAS DA SAUDE::MEDICINA
title_short Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi
title_full Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi
title_fullStr Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi
title_full_unstemmed Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi
title_sort Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi
author BARROS, Eduarda Pereira de
author_facet BARROS, Eduarda Pereira de
author_role author
dc.contributor.none.fl_str_mv OLIVEIRA, Simone Martins de
OLIVEIRA, Simone Martins de
SILVA, Maria Fernanda Piffer Tomasi Baldez da
dc.contributor.author.fl_str_mv BARROS, Eduarda Pereira de
dc.subject.por.fl_str_mv Bioterápicos
Doença de Chagas
Homeopatia
T. cruzi
CNPQ::CIENCIAS DA SAUDE::MEDICINA
topic Bioterápicos
Doença de Chagas
Homeopatia
T. cruzi
CNPQ::CIENCIAS DA SAUDE::MEDICINA
description The trypanosoma cruzi is a protozoan that causes a serious infeccion in the vertebrate host, being capable of causing irreversible damages, mainly in the muscle cells, also known as trypanosomiasis disease or Chagas Disease. The commercially avaible drug medication wich fights this parasite is not completly eficiente and causes undesireble and irreversible damages, making it necessary to search for other fields of medicine, in terms of medication, to combat this disease. Therefore, research with homeopathic medicines has being promising in the fight against the parasite, especially the amastigote forms, which are more difficult to be exterminated. Biotherapics are the homeopathic ones that have been more successful in relation to T. cruzi infection, since these drugs have their active principle removed from the parasite itself, its toxins, part of its members, performing a therapy known as isotherapy - cure by the same. The work was carried out with analysis of 100 histological slides, in 'zigzag', 'listing cells, infected or not by amastigotes, as well as cells of innate or acquired immunity. The work had the existence of three groups: control, treated continuously and treated only at the beginning of the infection. The results indicates that the 200dH biotherapic acts by coercing the immune system to fight T. cruzi in contaminated guinea pigs, promoting a cellular and humoral imune response more efficient than the physiological one. It is believed that this medicine works by stimulating the defense cells, which will respond in an antigenspecific manner, favoring the fight against amastigotes. This process is probably initiated by the stimulation of the macrophage, which in turn, according to the remains found, initiates an inflammatory cascade, with predominance of the Th1 pathway, promoting the production of IL-4e IL-5 and γ interferon, helping to combat amastigotes. With this result, the cure for homeopathy, of an infectious disease, shows promise, being an innovative and important field of medicine, requiring further investigation.
publishDate 2021
dc.date.none.fl_str_mv 2021-02-16T14:46:46Z
2021-02-16
2021-02-16T14:46:46Z
2021-02-16
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv BARROS, Eduarda Pereira de. Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi. 16f. 2020. Unicesumar - Universidade Cesumar: Maringá 2020.
Presencial
http://rdu.unicesumar.edu.br/handle/123456789/7576
identifier_str_mv BARROS, Eduarda Pereira de. Análise histopatológica dos efeitos do bioterapeutico 200dh em camundongos infectados por Trypanosoma cruzi. 16f. 2020. Unicesumar - Universidade Cesumar: Maringá 2020.
Presencial
url http://rdu.unicesumar.edu.br/handle/123456789/7576
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv UNIVERSIDADE CESUMAR
Brasil
UNICESUMAR
publisher.none.fl_str_mv UNIVERSIDADE CESUMAR
Brasil
UNICESUMAR
dc.source.none.fl_str_mv reponame:Repositório Digital Unicesumar
instname:Centro Universitário de Maringá (UNICESUMAR)
instacron:UniCesumar
instname_str Centro Universitário de Maringá (UNICESUMAR)
instacron_str UniCesumar
institution UniCesumar
reponame_str Repositório Digital Unicesumar
collection Repositório Digital Unicesumar
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1747771966397349888